1. Home
  2. RLMD vs HXHX Comparison

RLMD vs HXHX Comparison

Compare RLMD & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HXHX
  • Stock Information
  • Founded
  • RLMD 2004
  • HXHX 2003
  • Country
  • RLMD United States
  • HXHX China
  • Employees
  • RLMD N/A
  • HXHX N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HXHX Trucking Freight/Courier Services
  • Sector
  • RLMD Health Care
  • HXHX Industrials
  • Exchange
  • RLMD Nasdaq
  • HXHX Nasdaq
  • Market Cap
  • RLMD 20.3M
  • HXHX 19.0M
  • IPO Year
  • RLMD N/A
  • HXHX 2025
  • Fundamental
  • Price
  • RLMD $0.63
  • HXHX $1.00
  • Analyst Decision
  • RLMD Buy
  • HXHX
  • Analyst Count
  • RLMD 3
  • HXHX 0
  • Target Price
  • RLMD $5.00
  • HXHX N/A
  • AVG Volume (30 Days)
  • RLMD 142.9K
  • HXHX 135.5K
  • Earning Date
  • RLMD 08-07-2025
  • HXHX 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • HXHX N/A
  • EPS Growth
  • RLMD N/A
  • HXHX N/A
  • EPS
  • RLMD N/A
  • HXHX 0.26
  • Revenue
  • RLMD N/A
  • HXHX $25,571,810.00
  • Revenue This Year
  • RLMD N/A
  • HXHX N/A
  • Revenue Next Year
  • RLMD N/A
  • HXHX N/A
  • P/E Ratio
  • RLMD N/A
  • HXHX $3.78
  • Revenue Growth
  • RLMD N/A
  • HXHX N/A
  • 52 Week Low
  • RLMD $0.24
  • HXHX $0.84
  • 52 Week High
  • RLMD $3.98
  • HXHX $6.29
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.70
  • HXHX N/A
  • Support Level
  • RLMD $0.59
  • HXHX N/A
  • Resistance Level
  • RLMD $0.64
  • HXHX N/A
  • Average True Range (ATR)
  • RLMD 0.05
  • HXHX 0.00
  • MACD
  • RLMD 0.00
  • HXHX 0.00
  • Stochastic Oscillator
  • RLMD 55.00
  • HXHX 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

Share on Social Networks: